143 related articles for article (PubMed ID: 22101281)
1. Extrusion printed polymer structures: a facile and versatile approach to tailored drug delivery platforms.
Rattanakit P; Moulton SE; Santiago KS; Liawruangrath S; Wallace GG
Int J Pharm; 2012 Jan; 422(1-2):254-63. PubMed ID: 22101281
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable polyesterurethanes with shape-memory properties for dexamethasone and aspirin controlled release.
Feng Y; Zhang S; Wang H; Zhao H; Lu J; Guo J; Behl M; Lendlein A
J Control Release; 2011 Nov; 152 Suppl 1():e21-3. PubMed ID: 22195859
[No Abstract] [Full Text] [Related]
4. A facile way to fabricate polyester microcapsules.
Yu X; Zhu J
J Control Release; 2011 Nov; 152 Suppl 1():e128-9. PubMed ID: 22195798
[No Abstract] [Full Text] [Related]
5. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
[TBL] [Abstract][Full Text] [Related]
6. Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings.
Shen J; Burgess DJ
Int J Pharm; 2012 Jan; 422(1-2):341-8. PubMed ID: 22016033
[TBL] [Abstract][Full Text] [Related]
7. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
[TBL] [Abstract][Full Text] [Related]
8. Prediction of dexamethasone release from PLGA microspheres prepared with polymer blends using a design of experiment approach.
Gu B; Burgess DJ
Int J Pharm; 2015 Nov; 495(1):393-403. PubMed ID: 26325309
[TBL] [Abstract][Full Text] [Related]
9. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.
Mao S; Xu J; Cai C; Germershaus O; Schaper A; Kissel T
Int J Pharm; 2007 Apr; 334(1-2):137-48. PubMed ID: 17196348
[TBL] [Abstract][Full Text] [Related]
10. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
[TBL] [Abstract][Full Text] [Related]
11. Drug release from biodegradable polyesterurethanes with shape-memory effect.
Feng Y; Zhang S; Wang H; Zhao H; Lu J; Guo J; Behl M; Lendlein A
J Control Release; 2011 Nov; 152 Suppl 1():e20-1. PubMed ID: 22195852
[No Abstract] [Full Text] [Related]
12. Release profile characteristics of biodegradable-polymer-coated drug particles fabricated by dual-capillary electrospray.
Lee YH; Mei F; Bai MY; Zhao S; Chen DR
J Control Release; 2010 Jul; 145(1):58-65. PubMed ID: 20346381
[TBL] [Abstract][Full Text] [Related]
13. Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism.
Berkland C; Pollauf E; Raman C; Silverman R; Kim K'; Pack DW
J Pharm Sci; 2007 May; 96(5):1176-91. PubMed ID: 17455338
[TBL] [Abstract][Full Text] [Related]
14. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.
Klose D; Delplace C; Siepmann J
Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644
[TBL] [Abstract][Full Text] [Related]
15. High-throughput screening of PLGA thin films utilizing hydrophobic fluorescent dyes for hydrophobic drug compounds.
Steele TW; Huang CL; Kumar S; Widjaja E; Chiang Boey FY; Loo JS; Venkatraman SS
J Pharm Sci; 2011 Oct; 100(10):4317-29. PubMed ID: 21607953
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
17. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.
Keohane K; Brennan D; Galvin P; Griffin BT
Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
19. Nanoscale surface characterization and miscibility study of a spray-dried injectable polymeric matrix consisting of poly(lactic-co-glycolic acid) and polyvinylpyrrolidone.
Meeus J; Chen X; Scurr DJ; Ciarnelli V; Amssoms K; Roberts CJ; Davies MC; van Den Mooter G
J Pharm Sci; 2012 Sep; 101(9):3473-85. PubMed ID: 22447580
[TBL] [Abstract][Full Text] [Related]
20. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.
Song X; Song SK; Zhao P; Wei LM; Jiao HS
Pharm Dev Technol; 2013; 18(5):1220-9. PubMed ID: 22295954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]